carmustine has been researched along with Acute Disease in 39 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to strengthen the anti-leukemia effect, we developed a new conditioning regimen with high dose busulfan, VP-16 and ACNU (BVA) for cytoreduction before stem cell transplantation." | 9.07 | [High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia]. ( Fujioka, K; Funabiki, T; Ikuta, K; Kai, S; Kajigaya, Y; Matsuyama, S; Sakai, H; Sekiguchi, H; Sumita, H; Takahashi, H, 1993) |
| "Three hundred patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) were treated with cyclophosphamide, carmustine and etoposide and autologous stem cell support from 1986 through 1994." | 5.31 | Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV). ( Antin, J; Ault, K; Elias, A; Ibrahim, J; Khurshid, A; Mauch, P; Wheeler, C, 2001) |
| "In order to strengthen the anti-leukemia effect, we developed a new conditioning regimen with high dose busulfan, VP-16 and ACNU (BVA) for cytoreduction before stem cell transplantation." | 5.07 | [High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia]. ( Fujioka, K; Funabiki, T; Ikuta, K; Kai, S; Kajigaya, Y; Matsuyama, S; Sakai, H; Sekiguchi, H; Sumita, H; Takahashi, H, 1993) |
| "A total of 210 patients with supratentorial/nonmetastatic glioblastoma were treated with radiation therapy (RT) plus temozolomide from 2007 to 2016 and had laboratory data on total lymphocyte counts." | 3.88 | Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma. ( Campian, JL; Chang, X; Fergus, S; Hallahan, D; Huang, J; Hui, C; Lin, AJ; Mullen, D; Rao, YJ; Rudra, S; Samson, P; Thotala, D; Tsien, C; Yang, D, 2018) |
| "Based on experience with comprehensive patient involvement, we present data from implementation of portable, programmable infusion pumps (PPP) for home-based chemotherapy administration in patients with acute leukaemia and in lymphoma patients receiving (carmustine, etoposide, cytarabine, melphalan) BEAM regimen." | 3.88 | Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma. ( Dünweber, A; Fridthjof, KS; Friis, LS; Gørløv, JS; Kampmann, P; Kjeldsen, L; Moser, C; Møller, T; Nexø, C; Nørskov, KH; Welinder, PC, 2018) |
| "A 42-year-old male patient with a history of occupational exposure to benzene presented with pancytopenia." | 3.69 | t(9;13)(q34;q12) chromosomal translocation persisting 4 years post autologous bone marrow transplantation for secondary AML despite morphological remission. ( Mahendra, P; Marcus, RE; Nacheva, E; Richards, EM; Sinclair, P, 1996) |
| "Therapy with high-dose cyclophosphamide, cisplatin, and carmustine (BCNU) plus autologous bone marrow transplantation has been extensively studied as treatment for patients with stage II or III breast cancer who have a 70% or greater risk of developing metastatic disease." | 3.68 | Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. ( Bearman, SI; Dufton, C; Fisher, JH; Jones, RB; Matthes, S; Shpall, EJ; Stemmer, SM; Stephens, JK, 1993) |
| "Carmustine (BCNU) is an anticancer drug known to produce pulmonary fibrosis as a side effect within three years of treatment." | 3.68 | Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. ( Gattameneni, HR; Hasleton, PS; O'Driscoll, BR; Poulter, LW; Taylor, PM; Woodcock, AA, 1990) |
| "At ABMT, 17 patients were in untreated relapse and one was in third complete remission (CR)." | 2.68 | Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation. ( Bonanad, S; Carral, A; de la Rubia, J; Jarque, I; Larrea, L; López, F; Martín, G; Martínez, J; Picón, I; Sanz, GF; Sanz, MA; Sempere, A; Soler, MA, 1996) |
| "Six patients, four with Hodgkin's disease and two with non-Hodgkin lymphomas, developed leukemic complications, myelodysplasia (MDS) in four cases and overt acute myeloid leukemia (AML) in two." | 2.68 | High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. ( Geisler, C; Myhre, J; Pedersen, M; Pedersen-Bjergaard, J, 1997) |
| "Acute leukemia has developed in 14 patients." | 2.65 | The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia. ( Bailey, AJ; Bergsagel, DE; Langley, GR; MacDonald, RN; Miller, AB; White, DF, 1979) |
| "Three hundred patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) were treated with cyclophosphamide, carmustine and etoposide and autologous stem cell support from 1986 through 1994." | 1.31 | Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV). ( Antin, J; Ault, K; Elias, A; Ibrahim, J; Khurshid, A; Mauch, P; Wheeler, C, 2001) |
| "Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy." | 1.30 | High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999) |
| "We report a fatal case of acute interstitial pneumonitis in a patient treated with carmustine (BCNU) for a brain tumor." | 1.29 | Severe diffuse interstitial pneumonitis induced by carmustine (BCNU). ( Delaval, P; Desrues, B; Le Coz, A; Lena, H; Quinquenel, ML, 1994) |
| "Fifteen patients had chronic myelogenous leukemia in chronic phase or acute leukemia in first remission (standard risk) and twenty-eight patients with more advanced disease (high risk)." | 1.28 | Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation. ( Andersson, BS; Brunner, LJ; Huan, SD; LeMaistre, CF; Spencer, V; Spinolo, JA; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (38.46) | 18.7374 |
| 1990's | 15 (38.46) | 18.2507 |
| 2000's | 6 (15.38) | 29.6817 |
| 2010's | 3 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rudra, S | 1 |
| Hui, C | 1 |
| Rao, YJ | 1 |
| Samson, P | 1 |
| Lin, AJ | 1 |
| Chang, X | 1 |
| Tsien, C | 1 |
| Fergus, S | 1 |
| Mullen, D | 1 |
| Yang, D | 1 |
| Thotala, D | 1 |
| Hallahan, D | 1 |
| Campian, JL | 1 |
| Huang, J | 1 |
| Fridthjof, KS | 1 |
| Kampmann, P | 1 |
| Dünweber, A | 1 |
| Gørløv, JS | 1 |
| Nexø, C | 1 |
| Friis, LS | 1 |
| Nørskov, KH | 1 |
| Welinder, PC | 1 |
| Moser, C | 1 |
| Kjeldsen, L | 1 |
| Møller, T | 1 |
| Singh, V | 1 |
| Devata, S | 1 |
| Cheng, YC | 1 |
| Sun, T | 1 |
| Pashaei, S | 1 |
| Jaffrey, I | 1 |
| Ryder, J | 1 |
| Kang, HJ | 1 |
| Shin, HY | 1 |
| Choi, HS | 1 |
| Han, KS | 1 |
| Ahn, HS | 1 |
| Ingram, W | 1 |
| Devereux, S | 2 |
| Das-Gupta, EP | 1 |
| Russell, NH | 1 |
| Haynes, AP | 1 |
| Byrne, JL | 1 |
| Shaw, BE | 1 |
| McMillan, A | 1 |
| Gonzalez, J | 1 |
| Ho, A | 1 |
| Mufti, GJ | 1 |
| Pagliuca, A | 1 |
| Passe, S | 1 |
| Miké, V | 1 |
| Mertelsmann, R | 1 |
| Gee, TS | 1 |
| Clarkson, BD | 1 |
| Klingemann, HG | 1 |
| Shepherd, JD | 1 |
| Reece, DE | 1 |
| Barnett, MJ | 1 |
| Nantel, SH | 1 |
| Sutherland, HJ | 1 |
| Spinelli, JJ | 1 |
| Phillips, GL | 1 |
| Müller, MR | 1 |
| Seiler, F | 1 |
| Thomale, J | 1 |
| Buschfort, C | 1 |
| Rajewsky, MF | 1 |
| Seeber, S | 1 |
| Ikuta, K | 1 |
| Fujioka, K | 1 |
| Sumita, H | 1 |
| Takahashi, H | 1 |
| Sekiguchi, H | 1 |
| Kai, S | 1 |
| Kajigaya, Y | 1 |
| Funabiki, T | 1 |
| Sakai, H | 1 |
| Matsuyama, S | 1 |
| Lena, H | 1 |
| Desrues, B | 1 |
| Le Coz, A | 1 |
| Quinquenel, ML | 1 |
| Delaval, P | 1 |
| Jones, RB | 1 |
| Matthes, S | 1 |
| Shpall, EJ | 1 |
| Fisher, JH | 1 |
| Stemmer, SM | 1 |
| Dufton, C | 1 |
| Stephens, JK | 1 |
| Bearman, SI | 1 |
| Lyytikäinen, O | 1 |
| Elonen, E | 1 |
| Lautenschlager, I | 1 |
| Jokipii, A | 1 |
| Tiittanen, L | 1 |
| Ruutu, P | 1 |
| Mahendra, P | 1 |
| Richards, EM | 1 |
| Sinclair, P | 1 |
| Nacheva, E | 1 |
| Marcus, RE | 1 |
| de la Rubia, J | 1 |
| Sanz, GF | 1 |
| Martín, G | 1 |
| Sempere, A | 1 |
| Picón, I | 1 |
| Carral, A | 1 |
| Larrea, L | 1 |
| Martínez, J | 1 |
| Soler, MA | 1 |
| Bonanad, S | 1 |
| López, F | 1 |
| Jarque, I | 1 |
| Sanz, MA | 1 |
| Pedersen-Bjergaard, J | 1 |
| Pedersen, M | 1 |
| Myhre, J | 1 |
| Geisler, C | 1 |
| Laughlin, MJ | 1 |
| McGaughey, DS | 1 |
| Crews, JR | 1 |
| Chao, NJ | 1 |
| Rizzieri, D | 1 |
| Ross, M | 1 |
| Gockerman, J | 1 |
| Cirrincione, C | 1 |
| Berry, D | 1 |
| Mills, L | 1 |
| Defusco, P | 1 |
| LeGrand, S | 1 |
| Peters, WP | 1 |
| Vredenburgh, JJ | 1 |
| Harrison, CN | 1 |
| Gregory, W | 1 |
| Hudson, GV | 1 |
| Goldstone, AH | 1 |
| Hancock, B | 1 |
| Winfield, D | 1 |
| MacMillan, AK | 1 |
| Hoskin, P | 1 |
| Newland, AC | 1 |
| Milligan, D | 1 |
| Linch, DC | 1 |
| Meloni, G | 2 |
| Proia, A | 1 |
| Guerrisi, V | 1 |
| Cordone, I | 1 |
| De Cuia, R | 1 |
| Fenu, S | 1 |
| Mauro, FR | 1 |
| Pescarmona, E | 1 |
| Reato, G | 1 |
| Mandelli, F | 2 |
| Wheeler, C | 1 |
| Khurshid, A | 1 |
| Ibrahim, J | 1 |
| Elias, A | 1 |
| Mauch, P | 1 |
| Ault, K | 1 |
| Antin, J | 1 |
| Garban, F | 1 |
| Gallagher, M | 1 |
| Jouvin-Marche, E | 1 |
| Jacob, MC | 1 |
| Moine, A | 1 |
| Marche, PN | 1 |
| Sotto, JJ | 1 |
| Bergsagel, DE | 2 |
| Bailey, AJ | 1 |
| Langley, GR | 1 |
| MacDonald, RN | 1 |
| White, DF | 1 |
| Miller, AB | 1 |
| Schreml, W | 1 |
| Bargon, G | 1 |
| Anger, B | 1 |
| Kubanek, B | 1 |
| Heimpel, H | 1 |
| Pruzanski, W | 1 |
| Chuang, RY | 1 |
| Laszlo, J | 1 |
| Keller, P | 1 |
| Zeller, WJ | 1 |
| Ivankovic, S | 1 |
| Schmähl, D | 1 |
| Cardinali, G | 1 |
| Catalano, G | 1 |
| Hossfeld, DK | 1 |
| Tormey, D | 1 |
| Ellison, RR | 1 |
| Yau, JC | 1 |
| LeMaistre, CF | 1 |
| Andersson, BS | 1 |
| Huan, SD | 1 |
| Wallerstein, RO | 1 |
| Woo, SY | 1 |
| Spitzer, G | 4 |
| Spinolo, JA | 1 |
| Spencer, V | 1 |
| Brunner, LJ | 1 |
| Harousseau, JL | 2 |
| Milpied, N | 2 |
| Briere, J | 2 |
| Desablens, B | 2 |
| Leprise, PY | 2 |
| Ifrah, N | 2 |
| Gandhour, B | 2 |
| Casassus, P | 2 |
| O'Driscoll, BR | 1 |
| Hasleton, PS | 1 |
| Taylor, PM | 1 |
| Poulter, LW | 1 |
| Gattameneni, HR | 1 |
| Woodcock, AA | 1 |
| Petti, MC | 1 |
| Avvisati, G | 1 |
| Tafuri, A | 1 |
| Amadori, S | 1 |
| Dicke, KA | 2 |
| Jagannath, S | 3 |
| Walters, RS | 1 |
| Horwitz, LJ | 2 |
| Vellekoop, L | 2 |
| Zander, AR | 2 |
| Keating, M | 2 |
| McCredie, KB | 1 |
| Culbert, S | 1 |
| Larry, N | 1 |
| Cockerill, K | 1 |
| Hester, J | 1 |
| Horwitz, L | 1 |
| Donadio, D | 1 |
| Navarro, M | 1 |
| Izarn, P | 1 |
| Greene, MH | 1 |
| Boice, JD | 1 |
| Strike, TA | 1 |
| Lustman-Marechal, J | 1 |
1 review available for carmustine and Acute Disease
| Article | Year |
|---|---|
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Tr | 1994 |
8 trials available for carmustine and Acute Disease
| Article | Year |
|---|---|
Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Ant | 2004 |
[High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia].
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantati | 1993 |
Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
Topics: Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transpl | 1996 |
High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality | 1997 |
The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia.
Topics: Acute Disease; Adult; Aged; Alkylating Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combinati | 1979 |
Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmust | 1991 |
Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Amsacrine; Analysis of Variance; Antibiotics, Antineoplastic | 1991 |
Carmustine as a cause of acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Humans; Leukemia; Male; | 1985 |
30 other studies available for carmustine and Acute Disease
| Article | Year |
|---|---|
Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bevacizumab; Carmu | 2018 |
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.
Topics: Acute Disease; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmust | 2018 |
Carboplatin and docetaxel-induced acute pancreatitis: brief report.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmus | 2010 |
A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; CD2 A | 2003 |
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
Topics: Acute Disease; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2008 |
Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined | 1982 |
Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome.
Topics: Acute Disease; Carmustine; Cyclophosphamide; Cytarabine; DNA Repair; Doxorubicin; Drug Resistance; E | 1994 |
Severe diffuse interstitial pneumonitis induced by carmustine (BCNU).
Topics: Acute Disease; Adult; Brain Neoplasms; Carmustine; Fatal Outcome; Humans; Lung Diseases, Interstitia | 1994 |
Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplat | 1993 |
Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
Topics: Aclarubicin; Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmus | 1996 |
t(9;13)(q34;q12) chromosomal translocation persisting 4 years post autologous bone marrow transplantation for secondary AML despite morphological remission.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Benzene; Bone Marrow; Bone Mar | 1996 |
Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantat | 1998 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 1999 |
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carm | 2000 |
Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 2001 |
Immunotherapy by non-myeloablative stem cell transplantation: study of the immune reconstitution. Arguments for distinct cell subsets in skin and blood.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood; Blood Cells; Carmustine; CD8-P | 2000 |
[Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].
Topics: Acute Disease; Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; | 1978 |
Treatment of plasma cell myeloma with cytotoxic agents.
Topics: Acute Disease; Alkylating Agents; Bence Jones Protein; Bone Neoplasms; Carmustine; Cell Count; Cyclo | 1975 |
Effects of nitrosoureas on human DNA polymerase activities from acute and chronic granulocytic leukemia cells.
Topics: Acute Disease; Carmustine; Chronic Disease; DNA Nucleotidyltransferases; Granulocytes; Humans; Kinet | 1976 |
Chemotherapy of the transplantable acute leukemia L5222 in rats.
Topics: Acute Disease; Animals; Antineoplastic Agents; Asparaginase; Carmustine; Cell Division; Cyclophospha | 1975 |
[Models of polychemotherapy in acute leukemias].
Topics: Acute Disease; Antineoplastic Agents; Asparaginase; Carmustine; Cyclophosphamide; Cytarabine; Dacarb | 1975 |
Ph1-positive megakaryoblastic leukemia.
Topics: Acute Disease; Autoradiography; Blood Cell Count; Blood Platelets; Bone Marrow; Carmustine; Chromoso | 1975 |
Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy | 1992 |
Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
Topics: Acute Disease; Adolescent; Brain Neoplasms; Carmustine; Child; Female; Humans; Lung; Male; Pulmonary | 1990 |
Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Ma | 1987 |
The role of autologous bone marrow transplantation in acute leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Evaluation Studies as Topi | 1987 |
High-dose cyclophosphamide, BCNU, and etoposide followed by autologous bone marrow rescue as treatment for adult acute leukemia in relapse.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transp | 1986 |
High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmusti | 1987 |
[Neuromeningeal localizations in acute leukemia and non-Hodgkin's lymphoma. Protocol combining BCNU-cytosine arabinoside].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cytarabi | 1987 |
[Neuromeningeal irradiation during the treatment of acute lymphoblastic leukemia].
Topics: Acute Disease; Age Factors; Asparaginase; Carmustine; Central Nervous System; Child; Child, Preschoo | 1974 |